Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases

BIO Statement on Passage of Legislation Reauthorizing the SBIR/STTR Program

March 17, 2026

WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The SBIR/STTR program has a long and proven track…

Announcing Investor Connect Plus: A LaunchBio x BIO Partnership

March 2, 2026

Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready life sciences companies seeking aligned…

BIO Statement on Reintroduction of the PASTEUR Act

February 5, 2026

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act:"The introduction of the PASTEUR Act of…